Second Genome, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

Second Genome, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Second Genome, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
Second Genome, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 27, 2016
28 pages — Published Sep 27, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Second Genome, Inc. (Second Genome), formerly PhyloTech, Inc. which specializes in microbial research and drug discovery. It develops pipeline portfolio of therapeutic candidates for inflammatory bowel and metabolic diseases. Second Genome Solutions offers services such as PhyloChip community analysis; 16S v4 community analysis; inferred function; whole metagenomic profiling; metatranscriptomics profiling; nucelic acid isolation; custom informatics and collection kits. The company works in collaboration with other organizations such as Janssen Biotech and Mayo Clinic, among others to discover and develop the microbiome modulating therapeutics.

Second Genome, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed informat

  
Source:
Document ID
GDPH262318D
Country
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
Second Genome, Inc., Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201642
Second Genome, Inc., Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201661
Second Genome, Inc., Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201671
Second Genome, Inc., Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201681
Second Genome, Inc., Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 201692
Second Genome, Inc., Pharmaceuticals &Healthcare, Deal Details1114
  Venture Financing111
    Second Genome Raises USD8.4 Million in Extended Series B Financing112
    Second Genome Raises USD42.6 Million in Series B Financing132
    Second Genome Raises US$6.5 Million In Extended Series A Financing152
    Second Genome Secures US$5 Million In Series A Financing172
    PhyloTech Secures US$1.2 Million In Seed Financing191
  Partnerships201
    Second Genome Enters into Research Agreement with APC201
    Second Genome Enters into Agreement with Evotec211
    Second Genome Enters into Co-Development Agreement with Mayo Clinic Center for Individualized Medicine221
    Second Genome Enters Into Agreement With Janssen Biotech For Microbiome Drug Discovery232
Second Genome, Inc. - Key Competitors251
Key Employees261
Locations And Subsidiaries271
  Head Office271
Appendix281
  Methodology281
  About GlobalData281
  Contact Us281
  Disclaimer281

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "Second Genome, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 27, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Second-Genome-Inc-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-25431>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). Second Genome, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 27, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Second-Genome-Inc-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-25431>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research